Zhiwei Li

Characterising copy number polymorphisms using next generation sequencing data

Zhiwei Li, 2019 .

Anti-tumor immunity and ferroptosis of hepatocellular carcinoma are enhanced by combined therapy of sorafenib and delivering modified GO-based PD-L1 siRNAs.

Xiang Hu, K. Ren, J. Bu, 2022, Biomaterials advances.

Epigenetically modified AP-2α by DNA methyltransferase facilitates glioma immune evasion by upregulating PD-L1 expression

Shuanglin Xiang, K. Xiao, Xiaofeng Ding, 2023, Cell death & disease.

KCTD1 Downregulation Suppresses Hepatocellular Carcinoma by Regulating Angiogenesis and Influencing the HIF-1α/VEGF Pathway

Liu Yang, Liu Yang, P. Chu, 2021 .

833O A phase Ib study result of HMPL-689, a PI3Kδ inhibitor, in Chinese patients with relapsed/refractory lymphoma

R. Feng, Jianfeng Zhou, S. Fan, 2021, Annals of Oncology.